Is Pfizer's Vaccine Plan Fair?

Prognosis: Breakthrough

• Episode: Is Pfizer's Vaccine Plan Fair?
• Website: Prognosis: Breakthrough
• Feed URL: https://feeds.megaphone.fm/BLM8995439705
• Duration: 00:19:15
• Published: 2021-03-05 22:52

Vaccine distribution still has the feel of a zero-sum game. Five days after Israel received 700,000 doses of the Pfizer-BioNtech vaccine, Pfizer told other non-U.S. customers that it would cut supplies while it briefly closed a facility in Belgium. The disparity in vaccine allocation is the product of a company struggling to apportion doses while demand far exceeds supply. Stephanie Baker and Cynthia Koons reported for Bloomberg Businessweek that the company has determined how many doses a country gets through an opaque process that appears to involve a mix of order size, position in the queue, production forecasts, calls from world leaders, and of course the desire to make a profit. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com